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Mucosal innate lymphoid cells (ILCs) are an emerging population of diverse and heteroge-
neous immune cells, all with the unique ability to mount a rapid response against invading
pathogens.They are further divided into subsets based on their differing cell surface mark-
ers as well as in their functional specialization. In this review, we summarize recent reports
describing the importance of the transcription factor aryl hydrocarbon receptor (AHR) in
regulating the development of one of these subsets, the Type-17/22 ILCs, as well as in
the organization of postnatal lymphoid structures.We discuss the mechanisms behind the
AHR dependence for development in Type-17/22 ILCs as well as reviewing the proposed
physiological ligands that are mediating this effect.
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INTRODUCTION
INNATE LYMPHOID CELLS: HETEROGENEITY AND FUNCTIONAL
SPECIALIZATION
Mucosal innate lymphoid cells (ILCs) are a population of immune
cells that has broad roles in host immunity as well as main-
taining homeostasis between the host and its environment. As
their name suggests, ILCs are a family of lymphoid cells from the
innate immune system, and develop from hematopoietic precur-
sors (Spits and Di Santo, 2011). Murine ILCs are heterogeneous
and they include two major subsets that we will deﬁne here as
Type-17/22 ILCs and Type-2 ILCs. These major subsets can be
further divided to include subsets that differ in the expression
of cell surface markers as well as in their functional special-
ization. Type-17/22 ILCs comprise NKp46+ ILCs (also known
as NK-22 in humans; Satoh-Takayama et al., 2008; Cella et al.,
2009; Luci et al., 2009; Sanos et al., 2009), LTi-like ILCs (CD4+,
CD4− LTi-like cells; Takatori et al., 2009) and Thy1high Sca1+ ILCs
(Buonocore et al., 2010). These populations collectively known as
Type-17/22 ILCs, specialize in the production of IL-22 and/or IL-
17. Type-2 ILCs include “natural helper cells” (NH; Moro et al.,
2010), “nuocytes” (Neill et al., 2010), innate helper type-2 (Ih2)
cells (Price et al., 2010), and multipotent progenitor type-2 cells
(MPPtype2; Saenz et al., 2010) which specialize in the production
of IL-5 and IL-13. Type-17/22 ILCs (Cella et al., 2009; Cupedo
et al., 2009; Crellin et al., 2010) and Type-2 ILCs (Moro et al.,
2010; Mjösberg et al., 2011; Monticelli et al., 2011) have also
been described in humans. Most ILCs are ablated in Il2rc−/−
mice (Satoh-Takayama et al., 2008; Koyasu and Moro, 2011),
suggesting the requirement of a γc-associated cytokine receptor
for their development and/or expansion. Interestingly, an IL-22
producing innate splenic population independent of Rag2 and
the γc but resembling CD4− LTi-like ILCs have been described
(Dumoutier et al., 2011).Whether these cells represent a precursor
of intestinal IL-22 producing ILCs or its central counterpart has
yet to be determined. Type-17/22 ILC subsets are developmen-
tally related in their requirement for Id2 and RORγt expression, as
Id2 (Yokota et al., 1999; Satoh-Takayama et al., 2010) and RORγt
(Satoh-Takayama et al., 2008; Luci et al., 2009; Sanos et al., 2009)
deﬁcient animals have greatly reduced numbers of these ILCs. The
key transcription factors that drive development of Type-2 ILCs
are not well deﬁned.However, they seem to develop independently
of RORγt (Moro et al., 2010). In addition, while Type-17/22 ILCs
are largely conﬁned to gut and lung mucosa and found in low
numbers in secondary lymphoid organs, Type-2 ILCs have some
distinct tissue distribution. Similar to Type-17/22 ILCs, nuocytes,
MPPtype2, and Ih2 were found in spleen, lymph nodes, small intes-
tine, gut-associated lymphoid tissue, and liver; however and in
contrast to Type-17/22 ILCs, NH ILCs are uniquely localized in
“fat associated lymphoid clusters” (Moro et al., 2010). Although
the exact relationship among the Type-2 ILC subsets is currently
not as clear as the relationship among the Type-17/22 ILC sub-
sets, it is likely that Type-2 ILC subsets are strictly related and
may represent the same cell type with different tissue localization
although it cannot be excluded that they derive from a common
lymphoid precursor and represent different cell lineages (Yang
et al., 2011).
One of the main features that characterize Type-17/22 ILCs is
their ability to promptly respond to the inﬂammatory cytokine
IL-23 by secreting IL-22 and/or IL-17 (Sonnenberg et al., 2011).
IL-1β alongside IL-23 has been shown promote IL-17 and IL-22
production inmurine invariantNatural Killer T cells (Doisne et al.,
2011) and γδ T cells (Sutton et al., 2009), NKp46+ ILCs (Reyn-
ders et al., 2011), as well as sustaining IL-22 production in human
ILCs cultured in vitro (Cella et al., 2010; Hughes et al., 2010).
Interestingly, the lymphotoxin pathway has also been demon-
strated to play an important role in controlling IL-22 production
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by Type-17/22 ILCs (Wang et al., 2010; Tumanov et al., 2011).
Conversely, one of the primary characteristics of Type-2 ILCs is
their capacity to quickly respond to the inﬂammatory cytokines
IL-33 and/or IL-25 by producing IL-5 and IL-13. The unique abil-
ity to respond within hours to changing environmental cues has
demonstrated increasing evidence that ILCs play a critical role
in dictating appropriate tissue responses to incoming pathogens.
ILCs are crucial for limiting tissue damage at mucosal sites and
they provide the initial innate layer of protection while appropri-
ate adaptive responses are developing. The intrinsic ability of ILC
to quickly respond to cytokines closely resembles the long-ago rec-
ognized capacity of conventional NK cells to respond to IL-12 and
IL-18 by rapidly producing IFN-γ (Takeda et al., 1998). In light
of this unique attribute, IL-12 and IL-18 responding cells, includ-
ing conventional NK cells, should be viewed as Type-1 ILCs. The
characteristics of the ILC subsets are summarized in (Table 1).
Considering the relevance of ILCs in disease and homeostasis,
understanding the developmental pathways of ILCs is critical in
their manipulation toward therapeutic exploitation. Therefore,
increasing effort is ongoing into understanding how ILCs develop,
expand, differentiate, and respond to a rapidly changing environ-
ment. One of the main focuses of recent research has been the
attempt to elucidate transcriptional factors that are crucial for ILC
differentiation. Here in this review, we will discuss recent ﬁnd-
ings on the role of the transcription factors aryl hydrocarbon
receptor (AHR) and Notch in the development and function of
Type-17/22 ILCs.
THE ARYL HYDROCARBON RECEPTOR PATHWAY
Numerous studies have shown that AHR is a master regula-
tor of drug metabolism and that it mediates the biochem-
ical and toxic effects of dioxins, polyaromatic hydrocarbons,
and related compounds and has been reviewed (Nebert et al.,
1993; Wilson and Safe, 1998; Mimura and Fujii-Kuriyama, 2003;
Nguyen andBradﬁeld, 2008).WhileAHRwas initially identiﬁed as
a key regulator of xenobiotic metabolism, it has since been shown
to modulate the expression of certain genes and the activity of
other transcription factors to inﬂuence other cellular functions
such as apoptosis, proliferation, cell growth, and differentiation.
AHR contains a basic helix–loop–helix (bHLH) domain similar
to that present in many DNA-binding proteins, and is a member
of the Per–Arnt–Sim (PAS) superfamily of proteins which contain
proteins involved in detection of intracellular or environmental
changes, sensing light, oxygen, and circadian rhythm (Gu et al.,
2000). In the absence of agonists, AHR resides in the cytosol as
an inactive complex including the chaperones heat shock pro-
tein (Hsp90; Perdew, 1988), aryl hydrocarbon receptor interacting
protein (AIP; Carver and Bradﬁeld, 1997), and p23 (Kazlauskas
et al., 1999). The PAS domain on AHR is an important site for
agonist binding, which leads to a conformational change in AHR.
This change results in a modiﬁed interaction with its chaperones
and exposes a nuclear localization signal on AHR. After migrat-
ing into the nucleus, AHR heterodimerizes with another bHLH–
PAS protein known as the aryl hydrocarbon receptor nuclear
translocator (ARNT; Reyes et al., 1992) and this complex binds
speciﬁc enhancer sequences adjacent to target promoters called
dioxin responsive elements (DRE), inducing transcription of mul-
tiple target genes. These genes include xenobiotic metabolizing
monooxygenases such as the members of the Cytochrome P450
family Cyp1a1, Cyp1a2, and Cyp1b1, but also encompass a large
number of other genes involved in important developmental and
physiological processes (Nguyen and Bradﬁeld, 2008).
DEVELOPMENTAL DEFECTS IN AHR DEFICIENT MICE
The hypothesis that AHR has a role in development indepen-
dent of binding xenobiotics was greatly augmented through
Table 1 | Characteristics of ILC subsets.
TYPE-17/22 ILC: RESPONSIVETO IL-23 AND IL-1β
NKp46+ ILC (ILC22) LTi-like ILC Sca1+ Thy1high ILC
Secrete IL-22 CD4+, CD4− subsets Secrete IL-22 and IL-17
Secrete IL-22 and IL-17 Localized in large intestine
Postnatal lymphoid tissues (CP and ILF)
TYPE-2 ILC: RESPONSIVETO IL-33 AND/OR IL-25*
NH Nuocyte Ih2 Mpptype2
Secrete IL-5 and IL-13 Secrete IL-5 and IL-13 Secrete IL-5 and IL-13 Secrete IL-5 and IL-13
Localized in FALC
*Do not respond to IL-25 alone
TYPE-1 ILC: RESPONSIVETO IL-12 AND IL-18
NK cells
Secrete IFN-y
ILC, innate lymphoid cells; LTi, lymphoid tissue inducer; CP, cryptopatches; ILF, isolated lymphoid follicles; NH, natural helper; Ih2, innate helper type-2; MPPtype2,
multipotent progenitor cell; FALC, fat associated lymphoid clusters; NK, natural killer.
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the generation of three independent AHR deﬁcient animals
(Fernandez-Salguero et al., 1995; Schmidt et al., 1996; Shimizu
et al., 2000). Examination of AHR null mice revealed common
developmental anomalies (Lahvis et al., 2000) including increased
neonatal lethality, portal vascular hypertrophy, and patent ductus
venosus (DV;Esser,2009). Lymphocytes from the lymphnodes and
spleen were greatly reduced in the mouse generated by Fernandez-
Salguero et al. but a similar phenotype was not observed in the
other two knockout mice. While the explanation of these con-
trasting phenotypes is still unclear, the common developmental
defects in AHR deﬁcient mice provides evidence supporting the
hypothesis that AHR plays an important role in normal develop-
ment and thatAHR is regulating normal vascular or hematopoietic
development. This important impact on development would sug-
gest that AHR is more than simply a xenobiotic sensor, and thus
it is of importance to identify and characterize the vast diversity
of AHR ligands as well as elucidating the mechanism behind AHR
regulated development.
AHR IN THE IMMUNE SYSTEM
While AHR biology has mainly been focused on environmental
toxicology studies and more recently into its importance during
normal physiology and development, AHR has found its way into
mainstream immunology research in the past few years. Several
studies have identiﬁed the importance of AHR in both adap-
tive and innate immune systems and have recently been reviewed
(Stevens et al., 2009; Stockinger et al., 2011). The focus of this
reviewwill be centered on the emerging evidence connectingAHR,
its ligands, and intestinal immune function.
AHR AND TYPE-17/22 ILC
While the importance of AHR expression on the differentia-
tion and function of Th17, Treg, and DC subsets has been
described (Stockinger et al., 2011), recent reports have also demon-
strated AHR expression in human and murine mucosal RORγt-
dependent Type-17/22 ILCs (Kiss et al., 2011; Lee et al., 2011;
Qiu et al., 2011; Figure 1). Driven by the hypothesis that similar
to TH17 cells, AHR was necessary for the production of IL-22
in Type-17/22 ILCs, it was of great interest to test the impact
of AHR deﬁciency on the function and/or development of these
ILCs. Similar to the phenotype seen in AHR deﬁcient TH17 cells,
Peyer’s patches, and lamina propria cells isolated from the mucosal
tissues of AHR deﬁcient animals stimulated with IL-23 failed
to produce IL-22. Further investigation demonstrated that sur-
prisingly, AHR signaling in vivo was critical for the presence of
Type-17/22 ILCs cells and not simply for their ability to secrete
IL-22, as these cells were absent in Ahr−/− mice. AHR deﬁciency
affected NKp46+ ILCs as well as the CD4+ and CD4− LTi-like
ILCs. Histological examination of gut-associated secondary lym-
phoid structures found an interesting and unique phenotype in
AHR deﬁcient animals. While embryonically imprinted lymphoid
structures, including the mesenteric lymph nodes, Peyer’s patches,
and cecum-associated patches, remained largely intact in AHR
deﬁcient animals, the postnatally imprinted lymphoid structures
were severely diminished. These included small intestine lam-
ina propria cryptopatches (CPs) and isolated lymphoid follicles
(ILFs), as well as colon associated lymphoid patches.
FIGURE 1 |Transcription factors in type-17/22 ILC development.
Type-17/22 ILCs which include NKp46+ ILC, LTi-like ILC, andThy1 high
Sca1+ ILC, are derived from hematopoietic precursors which require the
expression of Id2. All subsets depend on the expression of RORγt for their
development and recent reports have also shown the importance of AHR
expression on the development of at least the NKp46+ and LTi-like ILC
subsets. AHR expression onThy1 high Sca1+ ILCs have as of yet not been
described. Induction of genes downstream of AHR such as Notch and c-kit
are also important in the development of NKp46+ and LTi-like ILC subsets
respectively. Whether LTi-like ILCs and NKp46+ ILCs correspond to
sequential developmental stages of the same cell type is unclear.
CPs AND ILFs
Cryptopatches and ILFs are well-organized structures along the
gastrointestinal tract that are thought to be functionally similar
to Peyer’s patches in serving as important sites for the induction
of protective mucosal immune responses (Lorenz and Newberry,
2004; Shikina et al., 2004). CPs are located in the lamina propria,
and are composed of clusters of RORγt+ LTi-like ILCs scattered
within the gastrointestinal tract. These structures are not present
at birth, but start to develop about 2weeks after birth. Their for-
mation depends on factors necessary for the development and
proper function of Type-17/22 ILCs such as IL-7 signaling (Adachi,
1998; Yoshida, 1999) and the expression of RORγt (Eberl et al.,
2004) but seem to be independent of B and T cells (Hamada
et al., 2002). Although original reports suggested that Type-17/22
ILCs required intestinal microbiota to develop (Satoh-Takayama
et al., 2008; Sanos et al., 2009), subsequent investigation failed
to conﬁrm the need for microbiota (Lee et al., 2011; Reynders
et al., 2011; Sawa et al., 2011). It is thought that inﬂammatory
signals acting through Nod1 (Bouskra et al., 2008) as well as
other TLRs during microbial colonization of the gut promote the
transition of CPs into ILFs. Accordingly, germ-free animals have
normal numbers of CPs (Kanamori et al., 1996) and medium-
size ILFs (Hamada et al., 2002) but reduced number of large-size
ILFs (Lorenz and Newberry, 2004). ILFs are thought to develop
from CPs as CCR6+CXCR5+ B cells are recruited through the
chemokines CCL20 and CXCL13 produced by epithelial cells and
dendritic cells respectively (McDonald et al., 2010; van de Pavert
and Mebius, 2010). These structures are quite dynamic and plas-
tic in nature, representing a spectrum of varying maturity states,
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possibly inﬂuenced by the constant interaction between the host
and its luminal contents.
Asmentioned earlier, the development of CPs and ILFs requires
factors involved in the proper functioning of Type-17/22 ILCs,
with AHR now added to the growing list. It is important to clar-
ify that AHR has broad expression patterns within different cell
types including immune cells. Therefore it was important to deter-
mine whether AHR signaling was critical in Type-17/22 ILCs or
was required in other subsets that orchestrate Type-17/22 ILC
recruitment to CPs and ILFs or to gut lamina propria. Using var-
ious conditional deletion mutants for AHR, it was found that the
requirement forAHR in the development of Type-17/22 ILCs (Kiss
et al., 2011; Lee et al., 2011) as well as the organization of CPs and
ILFs was indeed intrinsic to RORγt expressing cells. CPs and ILFs
from AHR conditional deletion mutants driven by RORγt-Cre
recombinase had the same phenotype as AHR null animals while
these structures from AHR conditional deletion mutants driven
by CD11c or Villin – Cre were unaffected (Kiss et al., 2011). These
studies seem to indicate that while AHR is expressed in intestinal
epithelial cells or other mucosal-associated immune populations,
AHR signaling within RORγt expressing ILCs is critical for their
development as well as the formation of CPs and ILFs.
PROPOSED MECHANISMS FOR AHR REQUIREMENT IN
TYPE-17/22 ILC DEVELOPMENT
C-KIT
What is the mechanism behind the AHR-mediated development
of Type-17/22 ILCs? Interestingly using similar approaches, two
different mechanisms have been proposed. AHR has been shown
to induce the transcription of many target genes, and it was impor-
tant to determine which of these target genes were important for
Type-17/22 ILC development. One study focused on the receptor
tyrosine kinase c-kit as a downstream target of AHR signaling (Kiss
et al., 2011). Type-17/22 ILCs are identiﬁed by their expression of
c-kit, and c-kit was shown to regulate intestinal ILC numbers and
lymph node organogenesis (Chappaz et al., 2010). Closer exami-
nation of the c-kit promoter uncovered two canonical xenobiotic
responsive (XRE) elements and ChIP analysis revealed the speciﬁc
interaction of AHR with these XRE elements within the c-kit pro-
moter. It is noteworthy to point out that AHR-driven upregulation
of c-kit has also been reported to be critical for the development
of epidermal resident γδ T cells (Li et al., 2011). Activation of
AHR with agonists in vitro demonstrated the induction of c-kit
transcription and this AHR-mediated transcription of c-kit was
abrogated when the XRE elements within the c-kit promoter were
mutated. It was also found that Kitwv/wv mice, which express a
receptor with impaired kinase activity thus severely reducing c-
kit signaling, also had decreased numbers of Type-17/22 ILCs
and severely diminished numbers of CPs and ILFs. Therefore
the conclusion from this study was that AHR-mediated transcrip-
tion stabilizes c-kit expression which is necessary for the stem cell
factor-dependent maintenance of the Type-17/22 ILC pool num-
bers and subsequent formation of postnatal lymphoid follicles.
Accordingly, this study showed that in AHR deﬁcient mice Type-
17/22 ILCs are found in normal numbers at early time points after
birth,but because of the lack of AHR signaling and c-kit expression
they do not survive in the AHR-devoid environment.
Along the same lines, a second study has also demonstrated
normal frequencies of intestinal Type-17/22 ILCs in WT or AHR
deﬁcient mice at embryonic day 17.5 (Qiu et al., 2011). This
study suggests that AHR is important for the survival and mainte-
nance of Type-17/22 ILCs. Intestinal Type-17/22 ILCs had higher
Annexin V staining as well as decreased expression of the anti-
apoptotic genes Bcl2 and Bcl2l1, perhaps through the reduction
of IL-7 in the large intestines of AHR deﬁcient mice. However
the exact mechanisms behind the regulation of AHR, IL-7, and
antiapoptotic genes need to be addressed further.
NOTCH
A third study has proposed the induction of Notch as the mech-
anism behind AHR-driven development of at least small intestine
lamina propria NKp46+ ILCs (Lee et al., 2011). Notch signaling
affects tissue renewal, maintenance, and cell differentiation deci-
sions across a broad range of cell types and at different steps during
cell lineage progression. Notch proteins are cell surface receptors,
four of which have been described in mammals: Notch1–Notch4
(Kopan and Ilagan, 2009). The requirement for Notch signaling
during T cell differentiation as well as activation is well char-
acterized and has been reviewed (Osborne and Minter, 2007).
Notch has also been implicated in the development of adult but
not fetal RORγt+ ILCs in vitro (Possot et al., 2011) as well as
in promoting the differentiation of TH17 cells (Mukherjee et al.,
2009; Keerthivasan et al., 2011). Another interesting report sug-
gested a potential Notch–AHR axis for IL-22 production through
the Notch induced generation of as of yet unknown endoge-
nous AHR ligands in CD4+ T cells (Alam et al., 2010). However
a connection between AHR signaling and the upregulation of
Notch have not been clearly demonstrated. AHR agonists admin-
istered in vivo resulted in the rapid induction of Notch genes
in both the liver and in the lamina propria cells isolated from
the small intestine. NK cell lines transfected with a constitutively
active form of AHR also upregulated Notch2, demonstrating that
AHR signaling in part, regulates the expression of Notch. Animals
lacking RBP-J in hematopoietic cells partially resembled the phe-
notype of AHR deﬁcient animals. RBP-J is the binding partner
of all Notch proteins and necessary for Notch signaling (Tanigaki
and Honjo, 2010). These animals showed a severe reduction of
NKp46+ ILCs in the small intestine lamina propria. However,
in contrast to AHR deﬁcient animals, the CD4+ LTi-like ILCs
were to some extent preserved. Subsequent histological examina-
tion of diffuse postnatal lymphoid follicles in the RBP-J deﬁcient
animals revealed intact CPs and ILFs, conﬁrming the presence
of functional LTi-like ILCs. It is possible that additional signals
downstream of AHR partially compensate for the lack of Notch
signaling in LTi-like ILCs. However, this dichotomy in the require-
ment for AHR by all Type-17/22 ILCs but the speciﬁc requirement
of Notch signaling by NKp46+ ILCs, open new and interesting
questions.
Fate mapping experiments of Type-17/22 ILCs have shown that
the frequencies of RORγt+NKp46+ ILCs increase with time after
birth, reaching a plateau 4–5weeks after birth (Sawa et al., 2010).
However, RORγt+CD4+ LTi-like ILCs have an opposite behavior,
as their frequencies steadily decrease over time after birth, reach-
ing a lower set point 2–3weeks after birth. This evidence raises the
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possibility that indeed NKp46+ ILCs only generate from adult,
most likely bone marrow derived, precursor cells through a path-
way that is both AHR and Notch-dependent. Although some of
these cells may localize into CPs and ILFs, they are mostly dis-
persed throughout the lamina propria and are irrelevant for CP
and ILF formation.On the contrary,CD4+ LTi-like ILCsdetectable
during the ﬁrst 2 weeks of age may still be of fetal origin, possi-
bly from the fetal spleen or fetal liver hematopoietic stem cells
(Mebius et al., 1997; Kim et al., 2008). These cells are AHR depen-
dent but, as suggested by in vitro experiments,Notch-independent
(Possot et al., 2011) for their development, and they may repre-
sent the critical clue in the generation of CP and ILF structures.
Interestingly, during our bone marrow chimera experiments (Lee
et al., 2011) when either Ahr−/− bone marrow or WT bone mar-
row were transferred into WT recipients, we noticed that some
of the CD4+ LTi-like ILCs cells were still of host origin 11weeks
post-bone marrow transfer. This ﬁnding suggests that some of
these cells are radioresistant. Therefore, it is possible that some of
the CD4+ LTi-like ILCs found in the adult mouse derive from
a putative fetal precursor that was seeded early on after birth
and slowly proliferate in locus, while other CD4+ LTi-like ILCs
derive from an adult precursor that depend on Notch signaling.
This hypothesis would explain the partial dependence of CD4+
LTi-like ILCs on Notch signaling. Further investigation and gen-
eration of new tools that allow inducible ablation of Type-17/22
ILCs at different time points before and after birth will be required
to determine whether this is indeed the case. Another interest-
ing observation is that AHR seems to selectively impact the cell
types responsible for the organization of CPs and ILFs which
develop postnatally, but not Peyer’s patches and other periph-
eral lymph nodes which are imprinted prenatally. This ﬁnding
not only suggests a temporal or environmental separation of these
processes, but perhaps heterogeneity in the cell types responsible
for their organogenesis. Even though the numbers and frequen-
cies of both CD4+ and CD4− LTi-like ILCs are impacted by AHR
deﬁciency,AHR seems to selectively effect the postnatal expansion
of CD4− LTi-like ILCs (Kiss et al., 2011). However it is unclear
from this study whether the observed expansion also included
NKp46+ ILCs which would agree with previously published stud-
ies (Sawa et al., 2010). Whether RBP-J expression and Notch
signaling also has selective effects on CD4− LTi-like ILCs has yet
to be determined.
EXOGENOUS AND ENDOGENOUS SOURCES OF AHR
LIGANDS; WHICH MATTERS THE MOST?
What are the AHR ligands responsible for development and/or
maintenance of Type-17/22 ILCs? Currently, known environmen-
tal ligands of AHR include halogenated aromatic hydrocarbons,
polychlorinated biphenyls (PCBs), and polycyclic aromatic hydro-
carbons (PAHs; Nguyen and Bradﬁeld, 2008). Endogenous AHR
ligands isolated from mammalian tissues have also been identiﬁed
(Song et al., 2002), and are currently an intense area of research.
Arachidonic acid metabolites, heme metabolites, and tryptophan
metabolites (Veldhoen et al., 2009), have been identiﬁed as having
AHR agonist activity and are well reviewed (Denison and Nagy,
2003; Nguyen and Bradﬁeld, 2008). Natural dietary compounds
are also an abundant source of AHR agonists. Indole-3-carbinol
(I3C) is a phytochemical found in cruciferous plants including
broccoli andBrussels sprouts. The acidic environment of the stom-
ach produces I3C acid-condensation products that have potent
AHR agonist activity (Bjeldanes et al., 1991). One such I3C deriva-
tive is indolo[3,2-b]carbazole (ICZ)which binds toAHRwith high
afﬁnity (Chen et al., 1995). Natural ﬂavonoids ubiquitously found
in fruits and vegetables were also found to activate AHR, includ-
ing chrysin, galangin, baicalein, genistein, daidzein, and apigenin
(Amakura et al., 2003; Zhang et al., 2003).
EXOGENOUS DIETARY SOURCES OF AHR LIGANDS
Two independent studies have focused on natural plant derived
dietary compounds found in the conventional rodent diet as a
source of AHR agonists (Kiss et al., 2011; Li et al., 2011). It was
demonstrated that replacing the conventional plant derived diet
with a synthetic, highly reﬁned form of rodent diet seemingly
devoid of plant products reduced the numbers of AHR dependent
cells in the gut including Type-17/22 ILCs (Kiss et al., 2011) as well
as intraepithelial (IEL) γδ T cells (Li et al., 2011). The addition
of I3C into this synthetic diet restored normal numbers of these
cell types, thus suggesting the importance of vegetable derived
dietary components rich in AHR ligands especially early in life for
the maintenance of immune populations within the gut mucosa.
These studies demonstrated a mechanistic link between dietary
compounds and themodulation of immune populations and their
functions. However, our preliminary data on diet supplemented
with AHR ligands are at odd with these results. It is possible that
in our settings the existence of alternative and unexpected sources
of AHR ligands (such as bedding or water), and slight variations
in the formula of the synthetic diets, as well as variations between
different suppliers might explain these discrepancies. Although
recent publications have demonstrated Type-17/22 ILCs develop
independently of the microbiota, it cannot be ruled out that the
differences observed with puriﬁed synthetic diets may also be a
result of variations between the microbiota in the mice housed
among the various animal facilities and their contribution to AHR
ligands. However, an alternative interpretation may be that, while
exogenous dietary derived AHR ligands may be playing a role
in certain circumstances, endogenous agonists are sufﬁcient in
a steady state condition to induce development or to maintain
Type-17/22 ILCs.
NATURAL ENDOGENOUS SOURCES OF AHR LIGANDS
While the physiologically relevant endogenous agonist has yet to be
concretely established, some attractive candidates have been iden-
tiﬁed. Kynurenine, a tryptophan metabolite generated from the
indoleamine-2,3 dioxygenase (IDO) pathway, has recently been
demonstrated to induce Cyp1a1 in bone marrow derived den-
dritic cells (Mezrich et al., 2010; Nguyen et al., 2010), as well as
in CD103+ mucosal dendritic cells (Matteoli et al., 2010). IDO
expression as well as its induction has been shown to be depen-
dent upon AHR signaling (Mezrich et al., 2010; Nguyen et al.,
2010), and IDO enzymatic dependent and independent mecha-
nisms of immunomodulation have been described (Pallotta et al.,
2011). Many studies have suggested that AHR expression in DCs is
critical to expand Treg through an IDO-dependent production of
the tryptophan catabolite kynurenine, that acts as an endogenous
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AHR ligand (Veldhoen et al., 2009; Mezrich et al., 2010; Nguyen
et al., 2010; Wu et al., 2011). This mechanism of Treg induction
is most likely highly active in tumors, since it has been recently
shown that kynurenine is abundantly expressed in many tumors
(Opitz et al., 2011). In tumors, however, kynurenine is not pro-
duced by the tryptophan metabolizing enzymes IDO1 and/or
IDO2,as in dendritic cells, but is uniquely generated by the enzyme
tryptophan-2,3 dioxygenase (TDO; Opitz et al., 2011). Given the
abundance of studies demonstrating the important role of tryp-
tophan metabolism in modulating immune responses, further
investigation into the AHR/kynurenine pathway in Type-17/22
ILCs is quite promising. While synthetic highly puriﬁed diets low
in AHR agonists may reduce the environmental contribution of
AHR ligands, it may be more difﬁcult to distinguish among other
factors such as nutrients, preservatives, as well as housing and bed-
ding variances. New ways to partially block formation or deplete
endogenousAHR ligandsmay be a promising avenue to dissect the
contribution of natural endogenous versus exogenous compounds
that drive the differentiation of Type-17/22 ILCs.
CONCLUSION
A recent string of publications connecting the classical dioxin
sensor AHR with the development and maintenance of mucosal
immune cell populations demonstrate an unexplored frontier in
mucosal immunology.While teasing out the source of these exoge-
nous and/or endogenous ligands is not clearly understood at this
moment, the hypothesis that dietary derived compounds are intri-
cately involved in the development of mucosal immune structures
as well as the maintenance of immune cells in the gutis quite
intriguing. Further studies will need to carefully characterize the
exact mechanism by which AHR signaling seems to be exerting
its effects, as well as identifying the natural ligands responsible;
either from endogenous compounds or from exogenous dietary
sources.
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